MALARIA AND ANTIMALARIAL DRUGS: FACTS AND FIGURES FROM THE RURAL SINDH, PAKISTAN
Main Article Content
Keywords
Malaria, Vivax, Falciparum, Antimalarials
Abstract
Background: Malaria is a very common and very ancient disease caused by the malarial parasites following bites by female mosquito of genus anopheles. There are four common variants of this parasite namely Plasmodium Vivax, Falciparum, Ovale and malarae. Objective: This research was planned to estimate the frequency distribution and nature of malaria cases in the remote rural area (Tando Adam District) of Sindh Province of Pakistan. Settings and duration of research: Pediatric and medical outpatient department of Teaching hospital of Suleman Roshan Medical College was the site of study while the research was conducted over one-year period of time (January 2024 to December 2024). Methods: Participants were chosen through non-probability convenient sampling, suspected malaria cases with age limits5 to 50 years broadly divided into <12 years and above 12 years of age. Patients suspected for pyrexia due to respiratory infections and urinary tract infections were not included in the study. Biographic data and blood samples were collected following informed written consent. Malaria tests were performed in the hospital lab and data was calculated analyzed using SPSS version 22. Results: The frequency and percentage of male and female patients in this study was 787(60.12%) and 522(39.88%) respectively. Out of total 1309 patients 1066(81.44%) patients were malaria negative whereas the positive cases were 243(18.56%) out of which 124(9.47%) were males and 119(9.09%) were females. Patients with positive malarial test below the age of 12 years were 78(32.23%) out of which 66(27.27%) were suffering from plasmodium vivax while12(4.96%) patients were plasmodium Falciparum positive. Patients above 12 years with malaria positive were 164(67.77%) out of which 137(56.61%) were found to be vivax positive and 27(11.16%) were falciparum positive.
Conclusion: Malaria caused by plasmodium vivax was most common in this region followed by falciparum with no major gender difference was observed. Majority of cases were observed in months from June to October. Artemether and Lumefantrine combination was the mostly prescribed antimalarial agent.
References
2. Singh B, Daneshvar C. Human infections and detection of Plasmodium knowlesi. Clin Microbiol Rev. 2013;26(2):165–184. doi:10.1128/ CMR.00079-12
3. Antony HA, Parija SC. Antimalarial drug resistance: an overview. Trop Parasitol. 2016;6(1):30. doi:10.4103/2229-5070.175081
4. White N. Plasmodium Knowlesi: The Fifth Human Malaria Parasite. The University of Chicago Press; 2008:172–173.
5. Guttery DS, Holder AA, Tewari R, Laura J. K. Sexual development in Plasmodium: lessons from functional analyses. PLoS Pathog. 2012;8(1):
e1002404. doi:10.1371/journal.ppat.1002404
6. Escalante AA, Pacheco MA, Riley LW, Blanton RE. Malaria molecular epidemiology: an evolutionary genetics perspective. Microbiol Spectr.
2019;7(4):7425. doi:10.1128/microbiolspec.AME-0010-2019
7. World Health Organization. World Malaria Report 2022. World Health Organization; 2022.
8. Belete TM. Recent progress in the development of new antimalarial drugs with novel targets. Drug Des Devel Ther. 2020;14:3875. doi:10.2147/ DDDT.S265602
9. Renslo AR. Antimalarial Drug Discovery: From Quinine to the Dream of Eradication. ACS Publications; 2013:1126–1128.
10. Wampfler R, Hofmann NE, Karl S, et al. Effects of liver-stage clearance by primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum. PLoS Negl Trop Dis. 2017;11(7):e0005753. doi:10.1371/journal.pntd.0005753
11. Fikadu and Ashenafi. Malaria: An Overview Infection and Drug Resistance 2023:16 3339–3347.
12. Lindsay SW, Thomas MB, Kleinschmidt I. Threats to the effectiveness of insecticide-treated bednets for malaria control: thinking beyond insecticide resistance. Lancet Glob Health. 2021;9(9):e1325–e1331. doi:10.1016/S2214-109X(21)00216-3.
13. Mathewos Alemu Gebremichael1, Tadesse Gebremedhin, Wondwossen Niguse, Girma Mamo, Bezuayehu Alemayehu et al. Evaluation of anti-malarial treatment for elimination of malaria in South West Ethiopia: a concurrent triangulation design for prompt decision. Malaria Journal (2025);24:237
14. Martin JL, Mosha FW, Lukole E, et al. Personal protection with PBO-pyrethroid synergist-treated nets after 2 years of household use against pyrethroid-resistant Anopheles in Tanzania. Parasit Vectors. 2021;14(1):1–8. doi:10.1186/s13071-021-04641-5
15. World Health Organization. Indoor Residual Spraying: An Operational Manual for Indoor Residual Spraying (IRS) for Malaria Transmission Control and Elimination. World Health Organization; 2015.
16. Tangena J-A-A, Hendriks CM, Devine M, et al. Indoor residual spraying for malaria control in sub-Saharan Africa 1997 to 2017: an adjusted retrospective analysis. Malar J. 2020;19(1):1–15. doi:10.1186/s12936-020-03216-6
17. Shibeshi MA, Kifle ZD, Atnafie SA. Antimalarial drug resistance and novel targets for antimalarial drug discovery. Infect Drug Resist. 2020;13:4047. doi:10.2147/IDR.S279433
18. Ouji M, Augereau J-M, Paloque L, Benoit-Vical F. Plasmodium falciparum resistance to artemisinin-based combination therapies: a sword of Damocles in the path toward malaria elimination. Parasite. 2018;25. doi:10.1051/parasite/2018027